Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

20100128 Pharma Twittersphere Part Ii

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all

20100128 Pharma Twittersphere Part Ii

  1. 1. Visualize the pharma twittersphere Friday, January 29, 2010
  2. 2. Over  past  18  month  big  pharma  set  up  a   presence  on  twiJer Start  of  twiJer  ac1vi1es 2008 2009 2010 @Boehringer @AstraZenecaUS @JNJComm @Amgen @Pfizernews @Novar1s @Roche_com @genentechnews @AstraZeneca @GSKUS Whydot twitter analysis Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis 2 Friday, January 29, 2010
  3. 3. Pfizer  leads  in  terms  of  followers  despite  late  start #  of  Followers  2  699 1  313 Avg  Dec  09 Avg  Jul  09 Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis 3 Friday, January 29, 2010
  4. 4. Great  divide  on  following  policy  amongst  pharma #  of  Following  600 392 Avg  Dec  09 Avg  Jul  09 Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis 4 Friday, January 29, 2010
  5. 5. Difference  in  updates  =  different  degrees  of  engagement? #  of  Updates  255 119 Avg  Dec  09 Avg  Jul  09 Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis 5 Friday, January 29, 2010
  6. 6. Boehringer  &  JNJ  lead  in  terms  of  engagement #  of  Following Average  following:  392 Average  Updates:  119 #  of  Updates Bubble  size  =  #  of  followers Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis Friday, January 29, 2010
  7. 7. Boehringer  &  JNJ  lead  in  terms  of  engagement #  of  Following The twitter engagement quardrant: above average followers, following and updates! Average  following:  392 Average  Updates:  119 #  of  Updates Bubble  size  =  #  of  followers Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis Friday, January 29, 2010
  8. 8. ...  Roche  &  AstraZeneca  moving  into  the  “engagement“  quadrant #  of  Following @Pfizer_news Avrg  following:  600 @genentechnews Avrg  Updates:  255 #  of  Updates Avrg  Bubble  size  =  #  of  followers Source:  www.twiJer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis Friday, January 29, 2010
  9. 9. 19%  of  pharma  followers,  or  3,034  twiJer  accounts  have   more  than  500  followers. % >500 followers 15% 14% 26% 20% 20% Avrg 19% Number of followers that are followed by Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 8 Friday, January 29, 2010
  10. 10. 32%  of  accounts  follow  more  than  1  pharma  account !"#$%&'($)*$&+"%%",-).&/0122&+"%%",-).3& &4&5256&$77"89#.&& :77"89#.&+"%%",;9<&*")-&#($9&=&$77"89#& 45>?&"@-)%$'& = 2,079  unique  twiJer  accounts Note:  Analysis  based  on  19%  accounts  with  >500  followers  that  follow  at  least  one  of  the  5  pharma  accounts  listed  above Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 9 Friday, January 29, 2010
  11. 11. Boehringer  &  JNJ  :  number  of  followers  with  >  2000  followers   2000-­‐  5000  followers >  5000  followers Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 10 Friday, January 29, 2010
  12. 12. Segmented  2,079  unique  pharma  followers  into  6  segments Service  providers:          Consul1ng  services,  agencies,  CROs,  pharma  vendors,  etc. Journalist/bloggers:  Trade,  industry  and  health  publica1ons,            journalists,  financial  analysts,  healthcare  bloggers  etc. Advocacy:                                      Pa1ent  advocacy,  cause/awareness  advocacy  etc. HCP/Stakeholders:        Physicians,  nurses,  regulators,  insurance  etc. Science/academia:        Scien1sts,  scien1fic  publica1ons,  faculty  etc. Other:                                                      Other  pharma  companies,  pharma  employees,            health  websites,  travel  vendors,  real  estate  agents,  other                vendors  individuals,  non-­‐iden1fiable  accounts Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 11 Friday, January 29, 2010
  13. 13. Service  providers,  journalists,  bloggers  and   advocates  make  up  57%  of  pharma  following !"#$%&'()'*+,-%&'.//("0*1'23455')(66(+%&17')(66(+,08'*(9'4'9:.&#.'.//("0*1' '304$)5&'6$/078/9$:--./012;$ ,--./012$ !"#$ !%#$ ""#$ "&#$ '#$ (#$ &#$ )&#$ *&#$ %&#$ +&#$ "&&#$ <1=9>$ ?9>@7-9$A>.@7B9>$ C./>0:D721EFD.GG9>2$ ,B@.-:-H$ IJKE?1:L9=.DB9>2$ ?-790M212E,-:B9N7:$ Note:  Analysis  based  on  19%  accounts  with  >500  followers  that  follow  at  least  one  of  the  5  pharma  accounts  listed  above Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 12 Friday, January 29, 2010
  14. 14. Service  providers  and  Journalist/bloggers  also  follow  most  of  the  pharma   accounts  with  an  overlap  of  36%  and  41%  respec1vely Service  providers Journalist/bloggers Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 13 Friday, January 29, 2010
  15. 15. Boehringer  counts  most  journalists  and  bloggers   amongst  its  followers,  while  JNJ  porholio  is  more  diverse !"#$%&'()'*+,-%&')(..(+%&/'01233')(..(+%&/4'5%&'567&#7'788("9*/'$:'/*7;%6(.<%&'/%=#%9*' Number followers F6G$&H)&($:CC.I3J<K$ (>500) D9/1:4/E$ &'#$ &+#$ ''#$ ')#$ %#$ *#$ Unique 2,079* B.C0/@7.8$ !%#$ &*#$ '&#$ ''#$ *#$ "#$ 506 =>?/1@3/A<$ !%#$ ('#$ '!#$ ,#$ %#$ +#$ 580 6.9:1;<$ !%#$ ()#$ '(#$ %#$ (#$ ,#$ 535 5657.88$ !"#$ (!#$ ''#$ "#$ +#$ (#$ 544 -./01234/1$ !"#$ &(#$ '*#$ ')#$ "#$ +#$ 869 )#$ !)#$ ()#$ +)#$ ")#$ '))#$ Total 3,074 LJ0/1$ M/192C/$N1.92O/1$ 5.I13:P2<JQRP.44/1<$ DO9.C:CS$ T7=QMJ:U/0.PO/1<$ MC2/3;<J<QDC:O/82:$ *  Excluding  overlap  of  32%   Note:  Analysis  based  on  19%  accounts  with  >500  followers  that  follow  at  least  one  of  the  5  pharma  accounts  listed  above Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 14 Friday, January 29, 2010
  16. 16. Novar1s  high  overlap  with  others,  Boehringer  followed  by  many   journalists,  bloggers  and  advocates  alone. Advocates Journalist/bloggers Source:  www.twiJer.com,  Dec  31st  2009;  whdotpharma  analysis 15 Friday, January 29, 2010

×